Jean-Claude Maurel on Medesis Pharma’s €7M IPO and Future Plans | Jean-Claude Maurel, CEO, Medesis Pharma SA. 00:10:00
Jean-Claude is the founder of Medesis Pharma and brings more than 30 years of experience in the research and development and commercialization of novel pharmaceutical product.After founding in 1985, Natura Medica, a pharmaceutical company commercialising natural product assets, , the company was acquired in 1990 by Ipsen-Beaufour. In 1991, he created a research company that after 10 years of chemical and pharmacological explorations, discovered the lipid constituents which are today the basis of the Aonys® technology.In 2003, he created Medesis Pharma by consolidating previous patents and know-how.
